G3BP1 and bladder transitional cell carcinoma: High G3BP1 levels are associated with a poor prognosis in patients with BLCA treated with anti‐PD‐L1 antibody; thus, the use of EGCG may also enhance the efficacy of ICIs in human BLCA.